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Abstract:
Background: Thalassemia is a genetic disease having 
3-7% carrier rate in Indians. It is transfusion dependent 
anemia having high risk of iron overloading. A clinical 
symptom  of  iron  overload  becomes  detectable  in 
second  decade  causing  progressive  liver,  heart  and 
endocrine glands damage. There is a need to assess 
iron overload in thalassemics below 5 years of age to 
protect them from complications at later age of life. 
Aims and objectives: Present study was undertaken to 
estimate  serum  iron  status  and  evaluate  serum 
transferrin saturation in both homozygous & hetero-
zygous form of thalassemia as an index of iron over-
load  among  children  of  one  to  five  years  of  age. 
Materials and Methods: Clinically diagnosed thirty 
cases  of  β  thalassemia  major  &  thirty  cases  of  β 
thalassemia  minor  having  severe  anemia,  hepato-
spleenomegaly and between 1 year to 5 years of age 
were included in study group and same age matched 
healthy  controls  were  included  in  the  study.  RBC 
indices and HbA, HbA2 and HbF were estimated along 
with serum iron & serum Total Iron Binding Capacity 
(TIBC) and serum transferrin levels. Results: Signifi-
cant difference was observed in hemoglobin levels 
between control and both beta thalassemia groups. 
Mean Corpuscular Volume (MCV) and Mean Corpus-
cular  Hemoglobin  (MCH)  values  were  reduced. 
Hemoglobin  electrophoresis  showed  the  elevated 
levels  of  HbF  and  HbA2  in  both  beta  thalassemia 
groups. Among serum iron parameters, serum iron, 
TIBC and transferrin saturation were elevated whereas 
serum transferrin levels were low in thalassemia major 
in children below 5 years of age. Conclusion: Although 
clinical symptoms of iron overload have been absent in 
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thalassemic children below five years of age, biochem-
ical iron overloading has started at much lower age 
which is of great concern. 
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Introduction:
Thalassemia is a genetic disease associated with 
improportionate globin chain synthesis. Based on 
affected globin chain it may be alpha thalassemia 
or beta thalassemia. Beta thalassemia carrier rate 
in India is around 3-7%, though higher frequency 
is seen in certain ethnic groups [1]. Thalassemia 
major is the severe transfusion dependent form of 
anemia. Major causes of morbidity & mortality in 
thalassemics are anemia and iron overload [2]. 
The progressive iron overload in thalassemics is 
the  side  effect  of  ineffective  erythropoiesis, 
increased gastrointestinal absorption of iron, lack 
of physiological mechanism for excreting excess 
iron and multiple blood transfusions resulting in 
hemochromatosis. Even elevated body iron over-
load is observed in milder form of thalassemia [3]. 
Though  survival  of  thalassemics  is  steadily 
increasing, the prevalence of complications due to 
iron overload remain high. Typically, the sympt-
oms of iron overload become detectable in second 
decade of life but, non-transferrin bound fraction 
of iron may have started accumulating from early 
life  and  its  toxic  effects  progressively  damage 
heart, liver and endocrine glands at later age [4].  Journal of Krishna Institute of Medical Sciences University
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Thus management of iron overload complication 
is the major focus of thalassemia treatment today 
[5].
Repeated laboratory assessment of iron status is 
necessary for monitoring and preventing of iron 
overload  in  thalassemia.  Routinely  serum  iron 
concentration,  Total  Iron  Binding  Capacity 
(TIBC) and serum ferritin reflects the iron status 
of the body [6]; however several additional factors 
influence their value in serum.  TIBC level incre-
ases in iron deficiency anemia whereas it is decre-
ased in anemia of chronic diseases. Unfortunately, 
results of TIBC are also affected by factors like 
malnutrition, inflammation or chronic infection, 
which are common in thalassemics. Ferritin is a 
storage  compound  for  iron  and  serum  ferritin 
levels  normally  correlate  well  with  total  iron 
stores, however, restricted availability and cost 
factor brings limitations in estimation. Addition-
ally, serum ferritin is an acute-phase reactant, gets 
elevated  in  inflammation,  chronic  infection,  or 
even in iron deficiency anemia.
TIBC  indirectly  measures  serum  transferrin,  a 
specific  iron  carrier  protein.  Serum  transferrin 
saturation  (Tfsat)  is  a  calculated  parameter 
obtained from serum iron concentration divided 
by  TIBC  and  expressed  as  a  percent.  Serum 
transferrin saturation is commonly used indicator 
for  inclining  iron  over  load.  Serum  transferrin 
saturation  reflects  true  status  of  body  iron  as 
values are not influenced by other factors or their 
effect will be minimal. Serum transferrin satura-
tion correlates well with the level of serum ferritin 
and hence the iron store of the body [7].
Present study was undertaken to estimate serum 
iron status and evaluate serum transferrin satura-
tion in both homozygous & heterozygous form of 
thalassemia as an index of iron overload among 
children of one to five years of age. The study also 
included  correlation  of  serum  iron  and  serum 
transferrin saturation, a calculated parameter, to 
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have insight of iron overload status. This may 
assist as a guide to minimize the toxic effect of 
iron  overload  developing  at  later  age  in 
thalassemics.
Material & Methods:
Present study of assessment for iron overload in 
beta thalassemics was conducted by Department 
of  Biochemistry  of  SDM  College  of  Medical 
Sciences  and  Hospital,  Dharwad,  Karnataka, 
India.  Clinically  diagnosed  thirty  cases  of  β 
thalassemia major & thirty cases of β thalassemia 
minor having severe anemia, Hepatospleenome-
galy between 1 to 5 years of age were included in 
study group. Same age matched healthy children 
were  selected  as  control  group.  The  informed 
written  consent  concern  forms  were  collected 
from parents of patients & normal group children. 
The present study was approved by Institutional 
Ethics  Committee.  Diagnosis  of  β  thalassemia 
was  made  first  by  clinical  examination  of 
hepatospleenomegaly,  RBC  indices  and  con-
firmed by estimating HbF and HbA2 concentra-
tions  on  hemoglobin  electrophoresis.  Study 
population consisted of following three groups, 
Group A: Subjects diagnosed as β thalassemia 
major (n=30) due to HbF more than 30%, HbA2 
more than 7% and age between 1 to 5 years.
Group B: Subjects diagnosed as β thalassemia 
minor (n=30) based on levels of HbF 1-3%, HbA   2
2-7%, HbA -90-95% and age between 1 to 5 years.
Group C: Control healthy children, age group 1 to 
5 years having HbF less than 1% and HbA  level  2
less than 3.5%. Children who did not show any 
bleeding  disorder  or  anemia  were  included  as 
control.  Patients  with  sickle  cell  anemia,  iron 
deficiency  anemia,  jaundice  and  any  bleeding 
disorders were excluded from the study.
Collection and Analysis of Blood Samples: 
Out of 5 ml blood sample collected by taking 
aseptic precaution, 2 ml was transferred to EDTA  Journal of Krishna Institute of Medical Sciences University Ó Ó
tube and remaining 3 ml was transferred to plain 
tube for serum separation. Precaution was taken to 
avoid any traces of hemolysis. A direct drop of 
blood was used for peripheral smear. 
2 ml blood collected in EDTA was used for RBC 
indices (Sysmax Transasia Co.) and hemoglobin 
electrophoresis.  Hb electrophoresis was perform-
ed at alkaline pH 8.6 using TBA buffer. HbA, 
HbA2  and  HbF  were  estimated  by  Platinum 
software provided by Helena – Alere diagnostics 
US. HbF was also estimated by alkali denaturation 
method modified by Betke [8]. 
3 ml of blood collected in plain tube was allowed 
to clot. After an hour clear serum was separated by 
centrifugation at 3000 rpm for 10 min & serum 
samples were analyzed for serum iron & serum 
TIBC  by  Giovanniello  &  Peters  method  of 
Bathophenanthroline  [9].  Serum  transferrin 
saturation  was  calculated  by  =  (Serum  iron  / 
Serum TIBC) x 100 [10]. Serum transferrin levels 
were estimated by Calorimetric method suggested 
by Lung Nan Lin et al [11].
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Demographic 
Criteria
Control Group
(n= 30)
Thalassemia Major
(n= 30)
Thalassemia Minor
(n= 30)
Age (Years) 1 – 5 1 – 5 1 – 5
Hb (gm %) 11.89 ± 0.89 5.44 ± 2.38** 7.36 ± 2.88**
Hb F 0.82 ± 0.74 34.8 ± 18.64** 4.29 ± 1.53*
Hb A2 2.38 ± 1.12 6.71 ± 8.62* 4.3 ± 1.01*
MCV (fl) 86 ± 6.2 69.18 ± 7.09 66.36 ± 10.39
MCH (pg) 25 ± 3.6 23.97 ± 5.58 20.67 ± 5.80
MCHC (%) 30 ± 4.4 32.27 ± 6.44 29.8 ± 4.03
H/O
Number of units of 
blood transfusion
Nil 13.52 ± 3.43
(Min-04; Max-19)
2.84 ± 1.25
(Min-01; Max-04)
Table 1: Blood Indices and Hemoglobin Levels in Control and Study Groups
* p < 0.05 - significant compared to control, ** p< 0.001- highly significant compared to 
control, NS – non significant
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Statistical Analysis:
Student's ‘t’ test was employed for statistical ana-
lysis. The comparison of the data between study & 
control group was done and expressed as mean ± 
SD. Pearson's correlation coefficients were used 
to observe correlation between two sets of param-
eters.
Results:
Table  1  shows  blood  indices  and  hemoglobin 
levels in study groups. 
Highly significant difference (P<0.001) was obse-
rved in hemoglobin levels between control and 
both beta thalassemia groups. Mean Corpuscular 
Volume (MCV) and Mean Corpuscular Hemoglo-
bin (MCH) values were reduced. On electrophore-
sis, significantly elevated (p<0.001) levels of HbF 
and  HbA2  were  observed  in  beta  thalassemia 
major group, whereas in case of beta thalassemia 
minor levels of HbF and HbA2 showed statisti-
cally significant (p<0.05) mild increase.
Among 90 children included in the present study, 
30 children were age matched controls and 30  Journal of Krishna Institute of Medical Sciences University Ó Ó 20
children each belonging to thalassemia major and 
thalassemia minor groups. Age of the patients at 
the time of this study ranged in between 1 to 5 
years (Mean age 2.38 years). 
Table 1 also shows that thalassemia major had 
higher  degree  of  anemia  as  compared  to 
thalassemia minor group. This anemia was treated 
by  blood  transfusion.  When  history  of  blood 
transfusion among thalassemia major and minor 
was  compared  thalassemia  major  had  received 
higher number of units of blood (13.52 ± 3.43) as 
compared  to  thalassemia  minor  group  (2.84  ± 
1.25). 
Table 2 describes serum iron parameters in control 
and study groups.When compared with controls, 
significant (p<0.05) increase in serum iron was 
observed in β thalassemia major group whereas 
observed  decrease  in  serum  iron  was  non-
significant in β thalassemia minor group. Upsurge 
in serum TIBC in β thalassemia major compared 
to  control  group  was  statistically  significant 
(p<0.05)  whereas  once  again  beta  thalassemia 
minor did not show any significant change. 
A calculated parameter, serum transferrin satura-
tion values were significantly increased (p<0.05) 
in  thalassemia  major  group,  but  decreased  in 
thalassemia minor but remained non-significant 
compared to control. Serum transferrin levels of 
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Demographic Criteria Control Group
(n= 30)
Thalassemia Major
(n= 30)
Thalassemia Minor
(n= 30)
Serum Iron (µmol/L) 21.01 ± 4.87 24.58 ± 7.611*
NS 17.95 ± 8.34
Serum TIBC (µmol/L) 50.38 ± 7.067 57.61 ± 18.78*
NS 51.64 ± 17.62
Serum Iron/TIBC ratio 0.42 ± 0.11
NS 0.45 ± 0.18 
NS 0.37 ± 0.19 
Transferrin Saturation (%) 39.06 ± 8.9 46.78 ± 16.56*
NS 37.19 ± 21.57 
Serum Transferrin (mg/dl) 220.6 ± 13.87 180.7 ± 36.67**
NS 208.2 ± 43.4 
* p < 0.05 - significant compared to control, ** p< 0.001- highly significant compared to control, 
NS – non significant
Table 2: Serum Iron Parameters in Control and Study Groups
beta thalassemia major group illustrated signifi-
cant decrease (p<0.001) as compared with serum 
value  of  control  subjects  however,  thalassemia 
minor  presented  mild  decrease  without  any 
statistical significance.  
Discussion:
Thalassemia is a genetic disease where individu-
als show iron overload with anemia. This is due to 
improportionate globin chain synthesis leading to 
decreased normal hemoglobin levels. Microcytic 
anemia is a common observation in thalassemia. 
Beta thalassemia major which is due to homozy-
gous deletion of beta globin chain gene and patient 
suffers  severe  hemolytic  anemia,  whereas  beta 
thalassemia minor is heterozygous form, which 
remains  asymptomatic  or  with  mild  form  of 
anemia.  Beta  thalassemia  minor  usually  show 
microcytosis  with  normal  or  increased  RBC 
count. Elevated HbA2 is found in iron deficiency 
but, elevated HbA2 with normal to mildly elevated 
HbF  level  is  diagnostic  and  point  towards 
thalassemia, which coincides with our findings. 
Scientific  reports  state  that  decreased  level  of 
MCV and MCH [12,13,14] with high HbA2 is 
indicative of beta thalassemia major while, higher 
than normal amount of both HbA2 and normal 
HbF means a milder form of thalassemia. Very low  Journal of Krishna Institute of Medical Sciences University Ó Ó 21
HbA and high level of HbF points to severity of 
thalassemia. Thus elevated level of HbA2 is the 
reliable marker of heterozygous beta thalassemia 
[15]. Our results correlate with existing scientific 
reports  that  beta  thalassemia  minor  exhibits 
milder form of anemia sometimes it goes asymp-
tomatic throughout whereas, thalassemia major is 
severe transfusion dependent anemia. Increased 
serum iron levels are observed in beta thalassemia 
major but not in minor, may be because of unrec-
ognizably deranged erythropoiesis in milder form 
of thalassemia where subjects rarely present with 
iron excess [16] whereas in addition to deranged 
erythropoiesis, thalassemia major needs supple-
ment of blood which loads extra iron. Transferrin 
saturation is the amount of transferrin bound to 
iron.  In  case  of  normal  individual  transferrin 
saturation is in the range of 20% to 50% but serum 
transferrin saturation more than 50% is suggestive 
of iron over load. Serum transferrin saturation in 
children with beta thalassemia major remains at 
higher side. In present study, it may be due to 
severe forms of beta thalassemia which is associ-
ated with multiple blood transfusions and defi-
ciency of hepcidin resulting in iron overload and 
the same is reflected in the form of increased 
serum transferrin saturation. If these levels reach 
above 85%, it is referred to as labile plasma iron. 
This  is  redox  active  and  responsible  for  iron 
related toxicity. This may be the cause of clinical 
symptoms  appearing  after  gradual  overload 
during  the  course  of  two  decades.  Our  results 
correlate well with the findings of Edwards CQ, et 
al [17] and Fargion et al [18] A significant positive 
correlation has been observed between transferrin 
saturation  &  serum  iron  in  thalassemia  major. 
Transferrin, a glycoprotein, controls the level of 
free iron in biological fluid [19]. Increased levels 
are  indicative  of  iron  deficiency  anemia  while 
decreased value points to iron overload diseases. 
Results  of  present  study  once  again  point  at 
inclined  overloading  of  iron  in  thalassemic 
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children at much early age. Children with beta 
thalassemia need repeated blood transfusions to 
maintain  their  hemoglobin  level.  Transfused 
blood loads iron in their body, which remains as 
non-transferrin bound iron and propagates oxygen 
related  damage  [20]  unless  made  to  excrete. 
Though  clinical  symptoms  of  iron  overload 
appear in second decade of life [21] in present 
study children below five years of age have not 
shown any severe clinical symptoms as they may 
be in the initial phase of iron over loading. But the 
biochemical iron overloading is apparent from the 
mildly decreased value of serum transferrin in 
thalassemia minor while, more obvious in tha-
lassemia  major  due  to  observed  moderately 
decreased transferrin levels. Surviving beta tha-
lassemics  may  suffer  from  such  iron  overload 
complications [22] because of poorly managed 
transfusion. Treatment of beta thalassemia needs 
proper management of iron overload to prevent 
complication and early mortality. 
Conclusion: 
Although clinical symptoms of iron overload are 
absent in thalassemic children below five years of 
age, biochemical iron overloading has started at 
much  lower  age  which  is  of  great  concern.   
Differentiating between the iron overload & sev-
ere anemia in thalassemic children are important 
not only for prognostic implication but also to 
avoid risk of iron toxicity. Prevalence of complica-
tions  due  to  iron  overload  observed  in  thalas-
semics  is  the  life  limiting  complication  which 
needs to be corrected for the longevity of suffering 
children.  
Acknowledgement: 
The author would like to express their gratitude to 
management for providing constant support for 
research. We appreciate our technical experts Mr. 
P  Guruswami  and  Mr.  Ajay  Kotkar  for  their 
technical help. We express our thanks to staff of 
biochemistry department for their support. Journal of Krishna Institute of Medical Sciences University Ó Ó 22
References:
*Author for Correspondence: Dr. Dhiraj J. Trivedi, Professor and Head, Department of Biochemistry, SDM College of 
Medical Sciences and Hospital, Sattur, Dharwad, Karnataka India. Cell: 9449756172 Email: dhiraj99trivedi@gmail.com
JKIMSU,    Vol. 3, No. 2, July-Dec 2014 Dhiraj J. Trivedi et. al.
1. Higgs  DR,  Thein  SL, Wood WG.  Distribution  and 
population genetics of the thalassemia. In: Weatherall 
DJ, Clegg JB, (eds). The Thalassemia Syndromes. 4th 
edition. Blackwell Science, Oxford 2001: 237-284.
2. Nadeem Ikram, Khalid Hassan, Muhammad Younas, 
SaminaAmanat.  Ferritin  Levels  in  Patients  of  Beta 
Thalassaemia  Major.  International  Journal  of 
Pathology 2004; 2(2):71-74.
3. Lukens JN. Iron metabolism and iron deficiency. In: 
Blood Diseases of Infancy and Childhood. Miller DR, 
Barhner RL (eds.), St Louis: Mosby, 1989: 170-198.
4. Giardina PJ, Grady RW. Chelation therapy in beta-
thalassemia:  an  optimistic  update.  Semin  Hematol 
2001; 38(4):360-366.
5. Olivieri NF, Brittenham GM. Iron-chelating therapy 
and  the  treatment  of  thalassemia.  Blood  1997; 
89(3):739-61.
6. Akpotuzor JO, Isong C, Okpokam DC, Etukudo MH. 
Levels of Serum Iron, Total Iron Binding Capacity, 
Transferrin  Saturation  Fraction  and  Packed  Cell 
Volume of Blood Donors in Calabar, Cross River State, 
Nigeria. Pakistan Journal of Nutrition 2008; 7(3); 500-
502. 
7. Wangruangsathit  S,  Hathirat  P,  Chuansumrit  A, 
Pakakasama  S,  Hongeng  S.  The  correlation  of 
transferrin  saturation  and  ferritin  in  non-
splenectomized  thalassemic  children.  J  Med  Assoc 
Thai 1999; 82 Suppl 1:S74-76.
8. Modified  Betke  method  for  the  estimation  of  HbF. 
Dacie  and  Lewis  Practical  Haematology;  Elsevier 
(eds) 11th edition. 
9. Peters T, Giovanniello TJ, Apt L, Ross JF. A simple 
improved method for the determination of serum iron. J 
Lab Clin Med 1956; 48: 280 
10. http://en.wikipedia.org/wiki/Transferrin_saturation
11. Lin  LN,  Mason  AB,  Woodworth  RC,  Brandts  JF. 
Calorimetric  studies  of  serum  transferrin  and 
ovotransferrin. Estimates of domain interactions, and 
study of the kinetic complexities of ferric ion binding. 
Biochemistry 1994; 33(7):1881-1888.
12. Klee GG, Fairbanks VF, Pierre RV, O'Sullivan MB. 
Routine  erythrocyte  measurements  in  diagnosis  of 
iron-deficiency anemia and thalassemia minor. Am J 
Clin Pathol 1976; 66(5):870-877.
13. Kotwal  J,  Saxena  R,  Choudhry  VP,  Dwivedi  SN, 
Bhargava M. Erythrocyte indices for discriminating 
thalassaemic  and  non-thalassaemic  microcytosis  in 
Indians. Natl Med J India 1999; 12(6):266-267.
14. Shine I, Lal S. A strategy to detect beta-thalassaemia 
minor. Lancet 1977; 1(8013):692-4.
15. Fortová H, Slavíková V, Musil F, Suttnar J, Brabec V. 
Diagnosis of beta-thalassemia on the basis of HbA2 
determination. Vnitr Lek 1995; 41(5):302-306.
16. Garcia PJ, Moreu AI, Asensio MA, Rueda GA. Disease 
caused by iron overload associated with minor beta 
thalassemia. An Med. Intern 1993; 10; 203.
17. Edwards CQ, Skolnick MH, Kushner JP. Coincidental 
nontransfusional iron overload and thalassemia minor: 
association with HLA-linked hemochromatosis. Blood 
1981; 58(4):844-848.
18. Fargion  S, Taddei  MT,  Cappellini  MD,  Piperno A, 
Fiorelli G. The iron status of Italian subjects with beta-
thalassemia trait. Acta Haematol 1982; 68(2):109-114.
19. Crichton RR, Charloteaux-Wauters M. Iron transport 
and storage. Eur J Biochem 1987; 164(3):485-506.
20. Laksmitawati  DR,  Handayani  S,  Udyaningsih-
Freisleben SK, Kurniati V, Adhiyanto C, Hidayat J, 
Kusnandar S, Dillon HS, Munthe BG, Wirawan R, 
Soegianto RR, Ramelan W, Freisleben HJ. Iron status 
and  oxidative  stress  in  beta-thalassemia  patients  in 
Jakarta. Biofactors 2003; 19(1-2):53-62.
21. Olivieri  NF.  The  beta-thalassemias.  N  Engl  J  Med 
1999; 341(2):99-109.
22. Arch G. Mainous, James M. Gill, and Peter J. Carek. 
Elevated serum transferring saturation and mortality. 
Ann Fam Med 2004; 2(2): 133–138.